Видео с ютуба Event: Asco Gi 2026

ASCO GI 2026 Innovations in Gastrointestinal Cancer Care 1

Pancreatic cancer highlights from ASCO GI 2026

ASCO GI 2026 takeaways

Highlights from ASCO GI 2026: HERIZON-GEA-01, ILUSTRO & BREAKWATER

Key clinical trial updates from ASCO GI 2023

ASCO GI Cancer - 19th Feb

Phase II study of durvalumab + olaparib in patients with metastatic pancreatic cancer and DDR genes

Optimising first-line treatment in gastric cancer through precision medicine

ASCO GI: IO and interventional oncology

Peritoneal carcinomatosis in gastric cancer: challenges with systemic therapy

Minimal residual disease (MRD) trials in colorectal cancer

Associations of 9p21 deletions on chemo outcomes in pancreatic ductal adenocarcinoma

ASCOGI26: Thejus Jayakrishnan, MD | Dana-Farber Cancer Institute

Asco Gi Zanidatamab Chemo Beneficial In Her2 Positive Gastroesophageal Cancer Mednews

Argy & Omnya - Aria [Live from Tomorrowland]

What is the future role of ctDNA as a biomarker in colorectal cancer?

AI-powered analysis examining mode of presentation and symptoms of colorectal cancer

NEOSUMMIT-01 shows perioperative toripalimab + chemo improves 3-year EFS & OS in gastric/GEJ cancer

Pancreatic Cancer Treatment Updates: ASCO 2025 Insights by Dr. Brian Wolpin, MD

Neoadjuvant epacadostat with short course radiotherapy in pts with locally advanced rectal cancer